SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Mkilloran who wrote (19400)3/9/1999 12:09:00 AM
From: Zebra 365  Respond to of 23519
 
<<Alibra moving along in Phase III trials and the future looks brighter for Gene Therapy with the work that DR G Christ is doing at Albert Einstein Medical center...Happy RATS

Now were hearing that the female Cats are Happy as well....>>

Mkilloran,

So happy Rats don't move the market but happy Cats do?

I had God over to the house tonight for a few beers. After a six-pack of Bud even He started to move in Mysterious Ways. Like the Vivus stock price.

So it goes. Po-te-WEET....

Zebra



To: Mkilloran who wrote (19400)3/9/1999 8:03:00 AM
From: betty moyers  Read Replies (1) | Respond to of 23519
 
I agree that this should help the negotiations.

I also wonder if negotiations for US are being targeted for an alibra launch as a whole new product rather than trying to push the old product MUSE. This would be a much better route now as Alibra is getting close to market time. Much smaller pellet. Simpler with only one dose. Entirely new name.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News